Search research articles
Contact Us
Filters
Showing results (341-350 of 369) with videos related to
Page
of 37
Sort By:
Peptides
|
January 1, 1986
Helodermin has a VIP-like effect upon canine blood flow
S Naruse, A Yasui, S Kishida, et al.
British Journal of Pharmacology
|
June 1, 1993
Thermodynamics of antagonist binding to rat muscarinic M2 receptors: antimuscarinics of the pridinol, sila-pridinol, diphenidol and sila-diphenidol type
M Waelbroeck, J Camus, M Tastenoy, et al.
Gastroenterology
|
September 1, 1992
Stimulation of rat pancreatic tumoral AR4-2J cell proliferation by pituitary adenylate cyclase-activating peptide
L Buscail, C Cambillau, C Seva, et al.
Peptides
|
November 1, 1982
Vasoactive intestinal peptide (VIP) and peptide having N-terminal histidine and C-terminal isoleucine amide (PHI) stimulate adenylate cyclase activity in human heart membranes
G Taton, P Chatelain, M Delhaye, et al.
European Journal of Biochemistry
|
April 15, 1987
Chemical, immunological and biological properties of peptides like vasoactive-intestinal-peptide and peptide-histidine-isoleucinamide extracted from the venom of two lizards (Heloderma horridum and Heloderma suspectum)
A Vandermeers, P Gourlet, M C Vandermeers-Piret, et al.
European Journal of Pharmacology
|
September 1, 1989
Affinity profiles of hexahydro-sila-difenidol analogues at muscarinic receptor subtypes
G Lambrecht, R Feifel, M Wagner-Röder, et al.
Peptides
|
January 1, 1986
Effector mechanisms of peptides of the VIP family
J Christophe, M Svoboda, M Lambert, et al.
European Journal of Biochemistry
|
February 1, 1992
Purification, primary structure and molecular cloning of a rat ribosomal protein showing homology with yeast ribosomal protein YL34
M Svoboda, E Ciccarelli, M C Vandermeers-Piret, et al.
FEBS Letters
|
July 29, 1991
The two forms of the pituitary adenylate cyclase activating polypeptide (PACAP (1-27) and PACAP (1-38)) interact with distinct receptors on rat pancreatic AR 4-2J cell membranes
P Robberecht, M C Woussen-Colle, P De Neef, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 1, 1993
Receptors for pituitary adenylate cyclase activating peptides in human pituitary adenomas
P Robberecht, P Vertongen, B Velkeniers, et al.
Page
of 37
Search research articles
Search
Showing results (341-350 of 369) with videos related to
Sort By:
Page
of 37
Peptides
|
January 1, 1986
Helodermin has a VIP-like effect upon canine blood flow
S Naruse, A Yasui, S Kishida, et al.
British Journal of Pharmacology
|
June 1, 1993
Thermodynamics of antagonist binding to rat muscarinic M2 receptors: antimuscarinics of the pridinol, sila-pridinol, diphenidol and sila-diphenidol type
M Waelbroeck, J Camus, M Tastenoy, et al.
Gastroenterology
|
September 1, 1992
Stimulation of rat pancreatic tumoral AR4-2J cell proliferation by pituitary adenylate cyclase-activating peptide
L Buscail, C Cambillau, C Seva, et al.
Peptides
|
November 1, 1982
Vasoactive intestinal peptide (VIP) and peptide having N-terminal histidine and C-terminal isoleucine amide (PHI) stimulate adenylate cyclase activity in human heart membranes
G Taton, P Chatelain, M Delhaye, et al.
European Journal of Biochemistry
|
April 15, 1987
Chemical, immunological and biological properties of peptides like vasoactive-intestinal-peptide and peptide-histidine-isoleucinamide extracted from the venom of two lizards (Heloderma horridum and Heloderma suspectum)
A Vandermeers, P Gourlet, M C Vandermeers-Piret, et al.
European Journal of Pharmacology
|
September 1, 1989
Affinity profiles of hexahydro-sila-difenidol analogues at muscarinic receptor subtypes
G Lambrecht, R Feifel, M Wagner-Röder, et al.
Peptides
|
January 1, 1986
Effector mechanisms of peptides of the VIP family
J Christophe, M Svoboda, M Lambert, et al.
European Journal of Biochemistry
|
February 1, 1992
Purification, primary structure and molecular cloning of a rat ribosomal protein showing homology with yeast ribosomal protein YL34
M Svoboda, E Ciccarelli, M C Vandermeers-Piret, et al.
FEBS Letters
|
July 29, 1991
The two forms of the pituitary adenylate cyclase activating polypeptide (PACAP (1-27) and PACAP (1-38)) interact with distinct receptors on rat pancreatic AR 4-2J cell membranes
P Robberecht, M C Woussen-Colle, P De Neef, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 1, 1993
Receptors for pituitary adenylate cyclase activating peptides in human pituitary adenomas
P Robberecht, P Vertongen, B Velkeniers, et al.
Page
of 37